Clinical Trial

Efficacy of IVMED-85 on Pediatric Myopia

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated September 29, 2023 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the safety and preliminary efficacy of a 1-year course of IVMED-85 eye drops for the treatment of pediatric myopia by assessing its safety effects on visual acuity and its effect on the change and/or progression of myopia. The main question\[s\] it aims to answer are: * Does IVMED 85 improve visual acuity * Does IVMED 85 slow or otherwise change the progression of myopia Participants will use eyedrops twice a day for one year. Researchers will compare IVMED 85 to a placebo.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-07.
Trial Details
NCT Number NCT05761795
Lead Sponsor iVeena Delivery Systems, Inc.
Conditions Myopia, Progressive
Enrollment 216 participants
Start Date 2024-02
Primary Completion 2026-05 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-09-29